Eric Karas

Insider Reports History

Location
San Diego, CA
Signature
/s/ Kathleen Scott, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Karas:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARS Pharmaceuticals, Inc. Chief Commercial Officer Common Stock 10.3K $175K $16.99 01 Jul 2025 Direct
ARS Pharmaceuticals, Inc. Chief Commercial Officer Stock Option (Right to Buy) 545K 01 Jul 2025 Direct

Insider Reports Filed by Eric Karas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SPRY ARS Pharmaceuticals, Inc. 01 Jul 2025 3 -$232K 4 Chief Commercial Officer 03 Jul 2025, 16:21
SPRY ARS Pharmaceuticals, Inc. 18 Jun 2025 3 -$218K 4 Chief Commercial Officer 20 Jun 2025, 18:38
SPRY ARS Pharmaceuticals, Inc. 20 Mar 2025 3 -$125K 4 Chief Commercial Officer 21 Mar 2025, 18:30
SPRY ARS Pharmaceuticals, Inc. 02 Jan 2025 1 $0 4 Chief Commercial Officer 03 Jan 2025, 16:30
SPRY ARS Pharmaceuticals, Inc. 02 Dec 2024 6 -$125K 4 Chief Commercial Officer 04 Dec 2024, 21:40
SPRY ARS Pharmaceuticals, Inc. 18 Sep 2024 3 -$125K 4 Chief Commercial Officer 19 Sep 2024, 16:30
SPRY ARS Pharmaceuticals, Inc. 19 Aug 2024 3 -$125K 4 Chief Commercial Officer 21 Aug 2024, 18:51
SPRY ARS Pharmaceuticals, Inc. 02 Jan 2024 1 $0 4 Chief Commercial Officer 04 Jan 2024, 16:47
SPRY ARS Pharmaceuticals, Inc. 03 Jan 2023 1 $0 4 Chief Commercial Officer 05 Jan 2023, 16:00
SPRY ARS Pharmaceuticals, Inc. 08 Nov 2022 1 $0 4 Chief Commercial Officer 10 Nov 2022, 17:00
SPRY ARS Pharmaceuticals, Inc. 08 Nov 2022 0 $0 3 Chief Commercial Officer 10 Nov 2022, 16:01